A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : HMII / HeartMate II

[Related PubMed/MEDLINE]
Total Number of Papers: 147
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HMII  (>> Co-occurring Abbreviation)
Long Form:   HeartMate II
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. BTC, BTT, DT, HM3, LVADs
2020 Classification of the Frequency, Severity, and Propagation of Thrombi in the HeartMate II Left Ventricular Assist Device. PT, VADs
2020 Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVAD. EPPY, HM3, VADs
2020 Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices. EMI, HM3, ICDs, LVADs, PMs
2020 Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. CF-LVAD, GIB, HVAD
2020 Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. HM3, HR, LVAD, MR
2020 Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. HM3, HR, HR, LVAD
2020 Long-term ungrounded cable support for short-to-shield syndrome. LVAD, PBU, STS
2020 Recurrent short-to-shield phenomenon requiring LVAD exchange: a rare complication. DL, LVAD, STS
10  2020 Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. LVADs, rpm
11  2019 Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. HM3, HM3
12  2019 Device exchange from HeartMate II to HeartMate 3 left ventricular assist device. HM3, IQR
13  2019 Device exchange from Heartmate II to HeartWare HVAD. LVAD
14  2019 Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II? HM3, HVAD, RCT
15  2019 Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends. LDH, LVAD
16  2019 Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis. HMIII, HVAD, LVAD
17  2019 Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial. HM3, HMWMs, vWF
18  2019 Evaluation of in vitro hemolysis and platelet activation of a newly developed maglev LVAD and two clinically used LVADs with human blood. LVAD, NIH, PFH
19  2019 Experience with the HeartMate II Left Ventricular Assist Device in Patients Older than 60 Years. LVAD, RRT
20  2019 Left ventricular assist device implantation with concomitant tricuspid valve repair: is there really a benefit? HMIII, LVAD, RHF, TVR
21  2019 Low-Dose Prothrombin Complex Concentrate in Patients with Left Ventricular Assist Devices. 4F-PCC, INR, LVADs, PCC
22  2019 Noninvasive Measures of Pulsatility and Blood Pressure During Continuous-Flow Left Ventricular Assist Device Support. AVO, BP, CF, DopBP, HVAD, LVAD, MAP, OR, PI, PP, SBP
23  2019 Postoperative bridging anticoagulation and left ventricular assist system thrombosis. INTERMACS, PTT
24  2019 Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device. BP, CI, HR, MAP, PP, SBP
25  2019 Survival and Functional Status After Bridge-to-Transplant with a Left Ventricular Assist Device. BTT, LVAD
26  2018 3D Morphological Changes in LV and RV During LVAD Ramp Studies. LV, LVAD, RV
27  2018 Association of Pulsatility with Gastrointestinal Bleeding in a Cohort of HeartMate II Recipients. CF-LVADs, GIB, PI
28  2018 Characterizing the HeartMate II Left Ventricular Assist Device Outflow Using Particle Image Velocimetry. AVWS, GI, PIV, RNSs, RSSs, VADs, vWF
29  2018 Clinical Outcome and Comparison of Three Different Left Ventricular Assist Devices in a High-Risk Cohort. HMIII, LVADs
30  2018 Clinical Outcomes of Patients With the HeartMate II Left Ventricular Assist Device: A Single-center Experience From Japan. LVAD
31  2018 Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation. BMI, CI, DLES, DLIs, VAD
32  2018 Effect of Preoperative Atrial Fibrillation on Patients with Chronic Heart Failure Who Undergo Long-Term Continuous-Flow LVAD Implantation. AF, CF-LVAD, CI, HVAD
33  2018 Five-year results of patients supported by HeartMate II: outcomes and adverse events. LVAD
34  2018 Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. HM3, HM3, HM3
35  2018 In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study. HMW vWF, VADs
36  2018 Normal fluid stresses are prevalent in rotary ventricular assist devices: A computational fluid dynamics analysis. ---
37  2018 Sildenafil Reduces the Risk of Thromboembolic Events in HeartMate II Patients with Low-Level Hemolysis and Significantly Improves the Pulmonary Circulation. fHb, HR, IS, LLH, NO, PT, TE, vWF
38  2018 Survival of HeartMate II Patients Despite Cessation of Anticoagulation - Outcomes and Hemostatic Analysis. AT, AVWS, IS, LVAD, PF, PT, TAT, VKA, vWF
39  2018 The Clinical Implication of Transcranial Doppler Detection of Microembolic Signals in Patients with Heartmate II. TCD
40  2018 Unrecognized Left Heart Failure in LVAD Recipients: The Role of Routine Invasive Hemodynamic Testing. CO, LVAD, RHCs
41  2017 A modified LVAD technique to augment caval and pulmonary arterial blood flow in the "failing Fontan" circulation. RPMs
42  2017 Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II. AVWS, HMW, VAD, VWF, vWF
43  2017 Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. HM3, HRAEs, LVAS
44  2017 Left ventricular assist device exchange: the Toronto General Hospital experience. LVADs
45  2017 Left Ventricular Assist Device Malfunctions: It Is More Than Just the Pump. DMs, HVAD, LVAD
46  2017 Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study. RT
47  2017 PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. INTERMACS, PT
48  2017 Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study. CI, HW, INR, MA-AA, MA-ADP, MCSD, TAH, TE, TEG PM
49  2017 Stopping conventional showering decreases Pseudomonas infections in left ventricular assist device patients. IQR, LVAD
50  2017 Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review. EPPY, ICH, LVAD
51  2017 Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. CF-LVADs
52  2017 The axial continuous-flow blood pump: Bench evaluation of changes in flow associated with changes of inflow cannula angle. ---
53  2017 Turbulence measurements in an axial rotary blood pump with laser Doppler velocimetry. LDV, VADs
54  2017 Ventricular Assist Device Implantation Configurations Impact Overall Mechanical Circulatory Support System Thrombogenic Potential. HA5, TP, VADs
55  2017 Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device. ---
56  2016 Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences. HR, HVAD, LVADs
57  2016 Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. DT LVAD
58  2016 Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey. INR, MCS
59  2016 Case Report: Disparate flow in HeartMate II patient with extensive left ventricle repair. DMCS, LV, LVAD, RV
60  2016 Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation. HVAD, LV, LVAD, RV, RVF
61  2016 Comparison of Mechanical Circulatory Support by the Use of Pulsatile Left Ventricular Assist Devices Polvad MEV and Continuous Flow Heart Ware and Heart Mate II in a Single-Center Experience. HW, LVAD
62  2016 Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility. CFD, HM3, LVAD, MIH, PfHb
63  2016 Effects of Left Ventricular Assist Device Support on End-Organ Function in Patients With Heart Failure: Comparison of Pulsatile- and Continuous-Flow Support in a Single-Center Experience. APTT, AST, HW, INR, LVADs, PM, POD
64  2016 HeartMate II Left Ventricular Assist Device Geometry on Chest Radiograph Does Not Correlate with Risk of Pump Thrombosis. AUC, ICA, LVADs, PPD, PT
65  2016 Investigation of the Characteristics of HeartWare HVAD and Thoratec HeartMate II Under Steady and Pulsatile Flow Conditions. LVADs
66  2016 Japanese Multicenter Outcomes With the HeartMate II Left Ventricular Assist Device in Patients With Small Body Surface Area. BSA, BTT
67  2016 Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device. BSA, BTT, CF-LVAD, DT
68  2016 Right Ventricular Function in Patients With Left Ventricular Assist Device Support by Pulsatile Polvad MEV and Continuous-Flow Pumps Heartware and Heartmate II. CI, CO, CVP, HW, LVAD, mPAP, PM, RV, RVW
69  2016 The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients. AT1R, HLA, LVAD
70  2015 Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis. CF-LVAD
71  2015 Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects. DLES, ESEM, VADs
72  2015 Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device. LVADs, PRBC
73  2015 Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions. EPPY, HW, LVADs
74  2015 Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. DE
75  2015 Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device. ---
76  2015 Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation. CF-LVAD, GIB
77  2015 Numerical Analysis of Blood Damage Potential of the HeartMate II and HeartWare HVAD Rotary Blood Pumps. LVADs
78  2015 Outcomes and hospital admissions during long-term support with a HeartMate II. BTT, DT
79  2015 Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. BSI, CF-LVAD, CVA, OR
80  2015 Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support. LVADs, RV
81  2015 Postoperative Outcomes of the Largest HeartMate-II Experience in Turkey. BTT, DT, FDA, INTERMACS
82  2015 Preservation of native aortic valve flow and full hemodynamic support with the TORVAD using a computational model of the cardiovascular system. TORVAD, VAD
83  2015 Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry. INTERMACS
84  2015 Radiologic assessment of HeartMate II position: Minimal pump migration after long-term support. ---
85  2015 Readmissions After Continuous Flow Left Ventricular Assist Device Implantation: Differences Observed Between Two Contemporary Device Types. HW
86  2015 Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry. DL, DT, SSI
87  2015 Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. 6MWD, HF, HRQoL, LVAD, LVADs, OMM
88  2015 Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study. LVAD, RT, US
89  2015 Ultraviolet Radiation Affects Thoratec HeartMate II Driveline Mechanical Properties: A Pilot Experiment. LVAD, UV
90  2015 Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device. AE, CCT, LVAD
91  2014 Acoustic analysis of a mechanical circulatory support. LVAD
92  2014 Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices. LVAD
93  2014 Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device. AF, HF, INRs, LVAD, PAF, PeAF
94  2014 Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. CF-LVADs, HF, LDH
95  2014 Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. PEL
96  2014 Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. CF-LVADs, GIB, HF, LVADs
97  2014 General and acute care surgical procedures in patients with left ventricular assist devices. ACS, LVADs
98  2014 Hemolysis in left ventricular assist device: a retrospective analysis of outcomes. LVAD
99  2014 Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. LVAD, VP
100  2014 Initial experience with routine less invasive implantation of HeartMate II left ventricular assist device without median sternotomy. ---